HUT77120A - Fibronektin adhézió-inhibítorok - Google Patents
Fibronektin adhézió-inhibítorokInfo
- Publication number
- HUT77120A HUT77120A HU9702198A HU9702198A HUT77120A HU T77120 A HUT77120 A HU T77120A HU 9702198 A HU9702198 A HU 9702198A HU 9702198 A HU9702198 A HU 9702198A HU T77120 A HUT77120 A HU T77120A
- Authority
- HU
- Hungary
- Prior art keywords
- adhesion inhibitors
- fibronectin adhesion
- fibronectin
- inhibitors
- adhesion
- Prior art date
Links
- 102000016359 Fibronectins Human genes 0.000 title 1
- 108010067306 Fibronectins Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9426254.0A GB9426254D0 (en) | 1994-12-24 | 1994-12-24 | Chemical compounds |
GBGB9505905.1A GB9505905D0 (en) | 1995-03-23 | 1995-03-23 | Methods |
GBGB9513904.4A GB9513904D0 (en) | 1995-07-07 | 1995-07-07 | Chemical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
HUT77120A true HUT77120A (hu) | 1998-03-02 |
Family
ID=27267539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9702198A HUT77120A (hu) | 1994-12-24 | 1995-12-21 | Fibronektin adhézió-inhibítorok |
Country Status (18)
Country | Link |
---|---|
US (1) | US6034056A (hu) |
EP (1) | EP0800535A1 (hu) |
JP (1) | JP3248584B2 (hu) |
CN (1) | CN1171118A (hu) |
AU (1) | AU705717B2 (hu) |
BR (1) | BR9510284A (hu) |
CA (1) | CA2204793A1 (hu) |
CZ (1) | CZ198497A3 (hu) |
GB (1) | GB9524630D0 (hu) |
HU (1) | HUT77120A (hu) |
IL (1) | IL116512A0 (hu) |
MX (1) | MX9704767A (hu) |
NO (1) | NO972930L (hu) |
NZ (1) | NZ297530A (hu) |
PL (1) | PL320995A1 (hu) |
SK (1) | SK81097A3 (hu) |
TR (1) | TR199501656A2 (hu) |
WO (1) | WO1996020216A1 (hu) |
Families Citing this family (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11508583A (ja) * | 1995-07-06 | 1999-07-27 | ゼネカ・リミテッド | ペプチド系のフィブロネクチン阻害薬 |
GB9613112D0 (en) | 1996-06-21 | 1996-08-28 | Zeneca Ltd | Chemical compounds |
PL323130A1 (en) | 1996-11-15 | 1998-05-25 | Hoechst Ag | Application of heterocyclic compounds in production of a pharmaceutic agent, novel heterocyclic compounds and pharmaceutic agent as such |
DE19647381A1 (de) | 1996-11-15 | 1998-05-20 | Hoechst Ag | Neue Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten |
DE19653036A1 (de) * | 1996-12-19 | 1998-06-25 | Merck Patent Gmbh | Cyclopeptidderivate |
US6221888B1 (en) | 1997-05-29 | 2001-04-24 | Merck & Co., Inc. | Sulfonamides as cell adhesion inhibitors |
US6291511B1 (en) | 1997-05-29 | 2001-09-18 | Merck & Co., Inc. | Biarylalkanoic acids as cell adhesion inhibitors |
US6903075B1 (en) | 1997-05-29 | 2005-06-07 | Merck & Co., Inc. | Heterocyclic amide compounds as cell adhesion inhibitors |
DE19741235A1 (de) | 1997-09-18 | 1999-03-25 | Hoechst Marion Roussel De Gmbh | Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
DE19741873A1 (de) * | 1997-09-23 | 1999-03-25 | Hoechst Marion Roussel De Gmbh | Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
US6069163A (en) * | 1997-10-21 | 2000-05-30 | Merck & Co., Inc. | Azapeptide acids as cell adhesion inhibitors |
US6020347A (en) * | 1997-11-18 | 2000-02-01 | Merck & Co., Inc. | 4-substituted-4-piperidine carboxamide derivatives |
DE19751251A1 (de) | 1997-11-19 | 1999-05-20 | Hoechst Marion Roussel De Gmbh | Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate |
US6191171B1 (en) | 1997-11-20 | 2001-02-20 | Merck & Co., Inc. | Para-aminomethylaryl carboxamide derivatives |
US6090841A (en) * | 1997-11-21 | 2000-07-18 | Merck & Co., Inc. | Substituted pyrrole derivatives as cell adhesion inhibitors |
US6645939B1 (en) | 1997-11-24 | 2003-11-11 | Merck & Co., Inc. | Substituted β-alanine derivatives as cell adhesion inhibitors |
DE19821483A1 (de) | 1998-05-14 | 1999-11-18 | Hoechst Marion Roussel De Gmbh | Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
DE19922462A1 (de) | 1999-05-17 | 2000-11-23 | Aventis Pharma Gmbh | Spiro-imidazolidinderivate, ihre Herstellung ihre Verwendung und sie enthaltende pharmazeutische Präparate |
EP2140881B1 (en) | 1999-12-16 | 2013-04-17 | Biogen Idec MA Inc. | Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
OA12126A (en) | 1999-12-28 | 2006-05-05 | Pfizer Prod Inc | Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune,and respiratory diseases. |
GB0015923D0 (en) * | 2000-06-30 | 2000-08-23 | Astrazeneca Ab | Methods |
DE10111877A1 (de) | 2001-03-10 | 2002-09-12 | Aventis Pharma Gmbh | Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
AU2002306777C1 (en) * | 2001-03-19 | 2008-04-24 | President And Fellows Of Harvard College | Evolving new molecular function |
DE10137595A1 (de) | 2001-08-01 | 2003-02-13 | Aventis Pharma Gmbh | Neue Imidazolidinderivate, ihre Herstellung und ihre Verwendung |
AU2002356180A1 (en) * | 2001-08-06 | 2003-03-10 | The Regents Of The University Of California | Methods for inhibiting angiogenesis |
AR038136A1 (es) | 2002-01-24 | 2004-12-29 | Merck Frosst Canada Inc | Cicloalcanindoles con sustitucion con fluor composiciones que contienen estos compuestos y metodos de tratamiento |
CA2503720A1 (en) | 2002-10-30 | 2004-05-21 | Merck & Co., Inc. | Gamma-aminoamide modulators of chemokine receptor activity |
US9403908B2 (en) | 2003-09-29 | 2016-08-02 | The Regents Of The University Of California | Method for altering hematopoietic progenitor cell adhesion, differentiation, and migration |
SE0302853D0 (sv) * | 2003-10-29 | 2003-10-29 | Astrazeneca Ab | Chemical compounds |
MXPA06011722A (es) | 2004-04-13 | 2007-01-25 | Incyte Corp | Derivados de piperazinilpiperidina como antagonistas del receptor de quimiocina. |
MEP1008A (xx) | 2005-12-21 | 2010-02-10 | Incyte Corp | 3-aminociklopentankarboksamidi kao modulatori receptora hemokina |
WO2007092471A2 (en) | 2006-02-03 | 2007-08-16 | The Regents Of The University Of California | Methods for inhibition of lymphangiogenesis and tumor metastasis |
WO2008103378A2 (en) | 2007-02-20 | 2008-08-28 | Merrimack Pharmaceuticals, Inc. | Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist |
FR2914304B1 (fr) * | 2007-03-28 | 2012-11-16 | Guerbet Sa | Composes pour le diagnostic de maladies liees a l'expression de vcam. |
WO2010031183A1 (en) | 2008-09-22 | 2010-03-25 | Merck Frosst Canada Ltd. | Indole derivatives as crth2 receptor antagonists |
CN102307896B (zh) * | 2008-10-31 | 2016-10-12 | 森托科尔奥索生物科技公司 | 基于iii型纤连蛋白结构域的支架组合物、方法及用途 |
US8969353B2 (en) | 2008-11-07 | 2015-03-03 | Massachusetts Institute Of Technology | Aminoalcohol lipidoids and uses thereof |
WO2010061329A1 (en) | 2008-11-26 | 2010-06-03 | Pfizer Inc. | 3-aminocyclopentanecarboxamides as chemokine receptor modulators |
TW201041892A (en) | 2009-02-09 | 2010-12-01 | Supergen Inc | Pyrrolopyrimidinyl Axl kinase inhibitors |
MA33134B1 (fr) | 2009-02-24 | 2012-03-01 | Merck Canada Inc | Derives d'indole en tant qu'antagonistes du recepteur crth2 |
US20120258093A1 (en) | 2009-08-20 | 2012-10-11 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Vla-4 as a biomarker for prognosis and target for therapy in duchenne muscular dystrophy |
US8853149B2 (en) | 2010-03-19 | 2014-10-07 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Integrin interaction inhibitors for the treatment of cancer |
EP2627178B1 (en) | 2010-10-11 | 2018-05-02 | Merck Sharp & Dohme Corp. | Quinazolinone-type compounds as crth2 antagonists |
CA2818597A1 (en) | 2010-12-23 | 2012-06-28 | Merck Sharp & Dohme Corp. | Quinoxalines and aza-quinoxalines as crth2 receptor modulators |
US9428845B1 (en) | 2010-12-28 | 2016-08-30 | Warp Drive Bio, Inc. | Identifying new therapeutic agents |
CA2831392C (en) | 2011-03-28 | 2020-04-28 | Massachusetts Institute Of Technology | Conjugated lipomers and uses thereof |
JP5934782B2 (ja) | 2011-05-04 | 2016-06-15 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | アミノ−ピリジン含有脾臓チロシンキナーゼ(Syk)阻害薬 |
CA2838731C (en) | 2011-06-17 | 2016-08-16 | Merck Sharp & Dohme Corp. | Cycloalkyl-fused tetrahydroquinolines as crth2 receptor modulators |
US8987456B2 (en) | 2011-10-05 | 2015-03-24 | Merck Sharp & Dohme Corp. | 3-pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors |
NZ747501A (en) | 2011-10-27 | 2020-05-29 | Massachusetts Inst Technology | Amino acid derivatives functionalized on the n-terminal capable of forming drug encapsulating microspheres |
CA2884870C (en) | 2012-08-13 | 2022-03-29 | Massachusetts Institute Of Technology | Amine-containing lipidoids and uses thereof |
WO2015048477A1 (en) | 2013-09-27 | 2015-04-02 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Cyclic peptide conjugates and methods of use |
GB201400292D0 (en) | 2014-01-08 | 2014-02-26 | Haemostatix Ltd | Peptide dendrimers and agents |
BR112016027705A2 (pt) | 2014-05-30 | 2018-01-30 | Shire Human Genetic Therapies | lipídios biodegradáveis para distribuição de ácidos nucleicos |
UA121863C2 (uk) | 2014-06-24 | 2020-08-10 | Транслейт Байо, Інк. | Стереохімічно збагачені композиції для доставки нуклеїнових кислот |
WO2016004202A1 (en) | 2014-07-02 | 2016-01-07 | Massachusetts Institute Of Technology | Polyamine-fatty acid derived lipidoids and uses thereof |
TW201629069A (zh) * | 2015-01-09 | 2016-08-16 | 霍普驅動生物科技股份有限公司 | 參與協同結合之化合物及其用途 |
EP3247378B8 (en) | 2015-01-09 | 2023-08-23 | Revolution Medicines, Inc. | Macrocyclic compounds that participate in cooperative binding and medical uses thereof |
RS64331B1 (sr) | 2015-06-19 | 2023-08-31 | Massachusetts Inst Technology | Alkenil supstituisani 2,5-piperazindioni i njihova primena u sastavima za isporuku agensa u organizam ili ćeliju subjekta |
JP7411326B2 (ja) | 2015-10-01 | 2024-01-11 | ワープ ドライブ バイオ インコーポレイテッド | タンパク質-タンパク質インターフェースを分析するための方法および試薬 |
CN109071602B (zh) * | 2015-11-11 | 2022-09-13 | 西兰制药公司 | 靶向α4β7整联蛋白的环肽 |
ES2921056T3 (es) | 2016-04-12 | 2022-08-17 | Warp Drive Bio Inc | Composiciones y métodos para la producción de compuestos |
CA3042231A1 (en) | 2016-10-28 | 2018-05-03 | Ginkgo Bioworks, Inc. | Compositions and methods for the production of compounds |
ES2884107T3 (es) * | 2016-11-11 | 2021-12-10 | Zealand Pharma As | Multímeros de péptidos cíclicos con diana en la integrina alfa-4 beta-7 |
WO2018140510A1 (en) | 2017-01-25 | 2018-08-02 | Biogen Ma Inc. | Compositions and methods for treatment of stroke and other cns disorders |
IL270465B (en) * | 2017-05-10 | 2022-09-01 | Encycle Therapeutics Inc | Cyclic peptides targeting alpha4beta7 integrin |
WO2020143793A1 (zh) | 2019-01-10 | 2020-07-16 | 石药集团中奇制药技术(石家庄)有限公司 | 杂环化合物盐及其应用 |
EP4055028A1 (en) | 2019-11-04 | 2022-09-14 | Revolution Medicines, Inc. | Ras inhibitors |
AU2020379731A1 (en) | 2019-11-04 | 2022-05-05 | Revolution Medicines, Inc. | Ras inhibitors |
MX2022005359A (es) | 2019-11-04 | 2022-06-02 | Revolution Medicines Inc | Inhibidores de ras. |
KR20230067635A (ko) | 2020-09-15 | 2023-05-16 | 레볼루션 메디슨즈, 인크. | 암의 치료에서 ras 억제제로서 인돌 유도체 |
EP4284947A1 (en) | 2021-01-29 | 2023-12-06 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Methods of assessing the risk of developing progressive multifocal leukoencephalopathy in patients treated with vla-4 antagonists |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZW6189A1 (en) * | 1988-05-09 | 1990-05-09 | Smithkline Beckman Corp | Anti-aggregatory peptides |
NZ235563A (en) * | 1989-10-13 | 1993-04-28 | Merck & Co Inc | Fibrinogen receptor antagonist and pharmaceutical composition |
US5192746A (en) * | 1990-07-09 | 1993-03-09 | Tanabe Seiyaku Co., Ltd. | Cyclic cell adhesion modulation compounds |
IL102646A (en) * | 1992-07-26 | 1996-05-14 | Yeda Res & Dev | Non-peptidic surrogates of the ldv sequence and pharmaceutical compositions comprising them |
EP0677060A1 (en) * | 1993-01-08 | 1995-10-18 | Tanabe Seiyaku Co., Ltd. | Peptide inhibitors of cell adhesion |
US5981478A (en) * | 1993-11-24 | 1999-11-09 | La Jolla Cancer Research Foundation | Integrin-binding peptides |
CA2193828A1 (en) * | 1994-06-29 | 1996-01-11 | Timothy P. Kogan | Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin |
US5811391A (en) * | 1994-08-25 | 1998-09-22 | Cytel Corporation | Cyclic CS-1 peptidomimetics, compositions and methods of using same |
DE69516848T2 (de) * | 1994-11-02 | 2000-12-07 | Koninkl Philips Electronics Nv | Wellenformerzeugung |
-
1995
- 1995-12-01 GB GBGB9524630.2A patent/GB9524630D0/en active Pending
- 1995-12-21 CA CA002204793A patent/CA2204793A1/en not_active Abandoned
- 1995-12-21 CZ CZ971984A patent/CZ198497A3/cs unknown
- 1995-12-21 CN CN95197007A patent/CN1171118A/zh active Pending
- 1995-12-21 US US08/860,248 patent/US6034056A/en not_active Expired - Fee Related
- 1995-12-21 BR BR9510284A patent/BR9510284A/pt unknown
- 1995-12-21 SK SK810-97A patent/SK81097A3/sk unknown
- 1995-12-21 WO PCT/GB1995/002992 patent/WO1996020216A1/en not_active Application Discontinuation
- 1995-12-21 EP EP95941215A patent/EP0800535A1/en not_active Withdrawn
- 1995-12-21 MX MX9704767A patent/MX9704767A/es unknown
- 1995-12-21 HU HU9702198A patent/HUT77120A/hu unknown
- 1995-12-21 AU AU42698/96A patent/AU705717B2/en not_active Ceased
- 1995-12-21 JP JP52028596A patent/JP3248584B2/ja not_active Expired - Fee Related
- 1995-12-21 PL PL95320995A patent/PL320995A1/xx unknown
- 1995-12-21 NZ NZ297530A patent/NZ297530A/en unknown
- 1995-12-22 IL IL11651295A patent/IL116512A0/xx unknown
- 1995-12-22 TR TR95/01656A patent/TR199501656A2/xx unknown
-
1997
- 1997-06-23 NO NO972930A patent/NO972930L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL116512A0 (en) | 1996-07-23 |
US6034056A (en) | 2000-03-07 |
PL320995A1 (en) | 1997-11-24 |
CA2204793A1 (en) | 1996-07-04 |
NO972930D0 (no) | 1997-06-23 |
CN1171118A (zh) | 1998-01-21 |
AU4269896A (en) | 1996-07-19 |
JP3248584B2 (ja) | 2002-01-21 |
SK81097A3 (en) | 1997-12-10 |
CZ198497A3 (en) | 1997-10-15 |
MX9704767A (es) | 1997-10-31 |
GB9524630D0 (en) | 1996-01-31 |
NZ297530A (en) | 2000-02-28 |
EP0800535A1 (en) | 1997-10-15 |
NO972930L (no) | 1997-08-19 |
BR9510284A (pt) | 1998-01-06 |
TR199501656A2 (tr) | 1996-07-21 |
WO1996020216A1 (en) | 1996-07-04 |
JPH10508315A (ja) | 1998-08-18 |
AU705717B2 (en) | 1999-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL320995A1 (en) | Fibronectin adhesion inhibitors | |
PL324491A1 (en) | Cell adhesion inhibitors | |
PL321759A1 (en) | Novel thrombosin inhibitors | |
EP0835109A4 (en) | PYRIDINONE-BASED THROMBIN INHIBITORS | |
PL331338A1 (en) | Thiosulphonamidic metaloprotease inhibitors | |
ZA967768B (en) | Cyclic adhesion inhibitors | |
EP0820453A4 (en) | THROMBIN INHIBITORS | |
GB9611422D0 (en) | Coated scale inhibitors | |
EP0743951A4 (en) | SUBSTITUTED LACTOSE DERIVATIVES AS CELL ADHESION INHIBITORS | |
ZA98376B (en) | Sulfamide-metalloprotease inhibitors | |
GB9416078D0 (en) | Ice inhibitor | |
GB2321641B (en) | Sulfamide-metalloprotease inhibitors | |
IL123653A0 (en) | Chemokine inhibitor | |
HUP9903631A3 (en) | Adhesion inhibitors | |
PL331803A1 (en) | Bidonoric metaloprotease inhibitors | |
GB9425701D0 (en) | Enzyme inhibitors | |
HU9400932D0 (en) | Linear adhesion inhibitors | |
HU9503783D0 (en) | Squvalen syntetase inhibitors | |
IL117437A0 (en) | Novel thrombin inhibitors | |
GB9502985D0 (en) | Enzyme inhibitors | |
DE69523450D1 (en) | Inhibitor | |
SG49610A1 (en) | Novel inhibitor | |
SI0805796T1 (en) | Cell adhesion inhibitors | |
SI0904285T1 (en) | Cyclic adhesion inhibitors | |
GB9601787D0 (en) | Inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DFD9 | Temporary protection cancelled due to non-payment of fee |